A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRS.
Int Forum Allergy Rhinol
; 2024 Jul 16.
Article
em En
| MEDLINE
| ID: mdl-39010849
ABSTRACT
KEY POINTS Novel topical therapeutics require extensive pre-clinical testing to assess efficacy and safety. Antibiofilm or immunosuppressant agents can utilize ex vivo models to measure ciliotoxicity. Agents that are found to be effective and non-toxic ex vivo warrant further investigation in vivo.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article